Naïve T Cell Depletion
Multi-Center Phase II Randomized Controlled Trial of Naïve T Cell Depletion for Prevention of Chronic Graft-Versus-Host Disease in Children and Young Adults
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 68 patients (estimated)
- Sponsors
- Fred Hutchinson / University of Washington Cancer Consortium
- Collaborators
- National Cancer Institute (NCI)
- Tags
- Allogeneic Stem Cell Transplant, Chemotherapy, T Cell, Radiation Therapy, Randomization
- Trial Type
- Supportive
- Last Update
- 2 weeks ago
- SparkCures ID
- 1689
- NCT Identifier
- NCT03779854
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.